About BONESUPPORT

News/Press Releases German
 

FIRST CERAMENT™|G STUDY WITH LOCAL GENTAMICIN ELUTION SHOWS SAFE BONE HEALING WITH EFFECTIVE NEW BONE INGROWTH IN OSTEOMYELITIS PATIENTS

15th April 2014

 

Lund, Sweden, (PRNEWSWIRE) April 15, 2014 – BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced the first patient outcomes data of CERAMENT™|G pertaining to an ongoing clinical trail in patients with osteomyelitis, as presented at The 4th Annual Oxford Bone Infection Conference. In the report, forty-one patients treated with CERAMENT™|G had no recurrence of infection, no late wound leakage, no toxicity and no renal complications at a mean follow-up of 9 months. Additionally, 78% of the patients demonstrated complete bone remodeling at 6 months.

CERTiFy (CERAMENT™|TIBIA FRACTURE) STUDY PROTOCOL PUBLISHED IN TRIALS

12th March 2014

 

Lund, Sweden, (PRNEWSWIRE) March 12, 2014 – BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, together with the University of Mainz in Germany, announced that the protocol for the CERAMENT™|Tibia Fracture Study (CERTiFy) was recently published in TRIALS, an open access, peer reviewed online journal. CERTiFy is a controlled, prospective, randomized clinical trial comparing the use of CERAMENT™|BONE VOID FILLER with the current gold standard for bone graft procedures in the management of tibia plateau fractures. CERTiFy will include 136 patients from more than a dozen top orthopedic trauma centers in Germany.

BONESUPPORT AB ANNOUNCES NEW DRILLING PERFORMANCE CAPABILITY FOR CERAMENT™|BONE VOID FILLER

11th March 2014

 

Lund, Sweden, (PRNEWSWIRE) March 11, 2014 – BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that a new drilling performance capability for CERAMENT™|BONE VOID FILLER is now reflected in the product’s Instructions for Use (IFU). The new claim allows for safe and effective drilling of CERAMENT™ during orthopedic surgical procedures.

Launch Of New CERAMENT™|G Registry To Collect Data In The Management Of Bone Infection

20th February 2014

 

LUND, Sweden, Feb. 19, 2014 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new registry to collect long term data of CERAMENT™|G, the first injectable antibiotic eluting, osteoconductive, ceramic bone substitute indicated to promote and protect bone healing being jeopardized by infection. The registry is part of the company's Centers of Excellence expansion plan and aims to advance research, discovery and the development of improved treatment protocols for osteomyelitis.